tiprankstipranks
Trending News
More News >
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market

NRX Pharmaceuticals (NRXP) Income Statement

Compare
681 Followers

NRX Pharmaceuticals Income Statement

Last quarter (Q3 2025), NRX Pharmaceuticals's total revenue was $242.00K, an increase of Infinity% from the same quarter last year. In Q3, NRX Pharmaceuticals's net income was $-5.89M. See NRX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -5.00K$ -5.00K$ -4.00K$ -2.00K$ -2.00K
Operating Expenses
$ 19.70M$ 27.58M$ 44.33M$ 95.20M$ 22.06M
Depreciation and Amortization
$ 5.00K$ 5.00K$ 4.00K$ 2.00K$ 2.00K
EBITDA
$ -24.04M$ -30.02M$ -39.75M$ -93.04M$ -51.72M
Operating Income
$ -19.70M$ -27.59M$ -44.34M$ -95.20M$ -22.06M
Other Income/Expenses
$ -5.42M$ -2.56M$ 4.58M$ 2.14M$ -29.72M
Pretax Income
$ -25.13M$ -30.15M$ -39.75M$ -93.06M$ -51.78M
Net Income
$ -25.13M$ -30.15M$ -39.75M$ -93.06M$ -51.78M
Per Share Metrics
Basic EPS
$ -2.39$ -3.98$ -0.60$ -7.44$ -1.51
Diluted EPS
$ -2.39$ -3.98$ -0.60$ -7.44$ -1.51
Weighted Average Shares Outstanding
10.52M 7.58M 65.77M 46.92M 546.59K
Weighted Average Shares Outstanding (Diluted)
10.52M 7.58M 65.77M 46.92M 546.59K
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History